Statutory rights violation and limitation period lapse lead to dismissal of substandard drug manufacturing case.
In a significant ruling, the Jammu & Kashmir and Ladakh High Court has quashed a complaint against Dr. Johns Pvt. Ltd., accused of manufacturing substandard drugs. The decision, pronounced by Justice Sanjay Dhar on July 10, 2026, emphasized procedural lapses and the deprivation of the accused's statutory rights under the Drugs and Cosmetics Act, 1940.
The case stemmed from a complaint filed by the Drugs Inspector, Zone-3, Srinagar, alleging that Dr. Johns Pvt. Ltd. manufactured "CADCAL capsules" that were not of standard quality. The complaint, however, was filed beyond the statutory limitation period, and the High Court found the cognizance taken by the Magistrate legally unsustainable.
The crux of the judgment lay in two pivotal issues: the delay in filing the complaint and the resultant impact on the accused's right to adduce evidence against the Government Analyst's report. The court noted that the period for taking cognizance of the alleged offense, which carries a maximum punishment of two years, had expired by the time the complaint was filed. Consequently, the Magistrate's order to issue process against the petitioner was deemed invalid.
Furthermore, the court highlighted the violation of Section 25(3) of the Drugs and Cosmetics Act, which allows the accused to challenge the Government Analyst's findings by adducing evidence within a specified timeframe. The drug in question had expired by the time the petitioner was informed about the report, rendering it impossible for Dr. Johns Pvt. Ltd. to exercise this right.
Justice Dhar pointed out the lack of any explanation for the delay in the complaint and the absence of reasons recorded by the Magistrate for condoning such delay under Section 538-G of the J&K Criminal Procedure Code. The judgment underscored the importance of adhering to procedural mandates to safeguard the rights of the accused.
Citing precedents from the Supreme Court and other High Courts, the judgment reiterated that any denial of the accused's statutory right to counter the analyst's report due to prosecution delays results in significant prejudice, warranting the quashing of the proceedings.
This ruling serves as a reminder of the judiciary's role in upholding procedural integrity and the rights of the accused, reinforcing the need for timely action by regulatory authorities in drug compliance cases.
Bottom line:-
Drugs and Cosmetics Act, 1940 - Complaint quashed where prosecution failed to adhere to mandatory requirements, resulting in deprivation of accused's statutory right to adduce evidence in controversion of Government Analyst's report.
Statutory provision(s): Drugs and Cosmetics Act, 1940 Sections 18(a)(i), 18(B), 27(d), 25(3); Criminal Procedure Code, Jammu & Kashmir Section 538-B, 538-G.
Dr. Johns Pvt. Ltd. v. State Of J&K, (Jammu & Kashmir And Ladakh) : Law Finder Doc id # 2941632
